UA111731C2 - STABILIZED COMPOSITION CONTAINING ANTIBODY TO INTERLAYKIN-4 (IL-4R) RECEPTOR, OPTIONS - Google Patents
STABILIZED COMPOSITION CONTAINING ANTIBODY TO INTERLAYKIN-4 (IL-4R) RECEPTOR, OPTIONSInfo
- Publication number
- UA111731C2 UA111731C2 UAA201305598A UAA201305598A UA111731C2 UA 111731 C2 UA111731 C2 UA 111731C2 UA A201305598 A UAA201305598 A UA A201305598A UA A201305598 A UAA201305598 A UA A201305598A UA 111731 C2 UA111731 C2 UA 111731C2
- Authority
- UA
- Ukraine
- Prior art keywords
- receptor
- composition containing
- interlaykin
- options
- containing antibody
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Винахід стосується стабільної рідкої фармацевтичної композиції, що містить людське антитіло, яке специфічно зв'язується з рецептором людського інтерлейкіну-4 (hIL-4R), де антитіло містить варіабельну ділянку важкого ланцюга, що містить амінокислотну послідовність SEQ ID NO: 1, і варіабельну ділянку легкого ланцюга, що містить амінокислотну послідовність SEQ ID NO:5, а також ацетат, гістидин, сахарозу, полісорбат, аргінін.The invention relates to a stable liquid pharmaceutical composition containing a human antibody that specifically binds to the human interleukin-4 receptor (hIL-4R), where the antibody contains a heavy chain variable region containing the amino acid sequence of SEQ ID NO: 1, and the variable sequence light chain containing the amino acid sequence of SEQ ID NO: 5, as well as acetate, histidine, sucrose, polysorbate, arginine.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39028310P | 2010-10-06 | 2010-10-06 | |
| PCT/US2011/054856 WO2012047954A1 (en) | 2010-10-06 | 2011-10-05 | Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA111731C2 true UA111731C2 (en) | 2016-06-10 |
Family
ID=45995014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201305598A UA111731C2 (en) | 2010-10-06 | 2011-05-10 | STABILIZED COMPOSITION CONTAINING ANTIBODY TO INTERLAYKIN-4 (IL-4R) RECEPTOR, OPTIONS |
Country Status (13)
| Country | Link |
|---|---|
| AR (1) | AR083338A1 (en) |
| DK (2) | DK2624865T3 (en) |
| ES (2) | ES2820246T3 (en) |
| HK (1) | HK1258305A1 (en) |
| HR (1) | HRP20181822T1 (en) |
| HU (1) | HUE052089T2 (en) |
| LT (1) | LT2624865T (en) |
| PT (1) | PT3354280T (en) |
| RS (1) | RS57850B1 (en) |
| SI (1) | SI2624865T1 (en) |
| TW (6) | TWI718890B (en) |
| UA (1) | UA111731C2 (en) |
| UY (1) | UY33652A (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201500889TA (en) | 2012-08-21 | 2015-03-30 | Sanofi Sa | Methods for treating or preventing asthma by administering an il-4r antagonist |
| TWI709411B (en) * | 2013-06-21 | 2020-11-11 | 法商賽諾菲生物技術公司 | Use of an il-4r antagonist for the manufacture of a medicament for treating nasal polyposis |
| HUE046410T2 (en) * | 2013-06-21 | 2020-03-30 | Sanofi Biotechnology | Methods for treating nasal polyposis by administering an il-4r antagonist |
| EP3218412A1 (en) | 2014-11-14 | 2017-09-20 | Sanofi Biotechnology | Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist |
| PL3703818T3 (en) | 2017-10-30 | 2024-03-25 | Sanofi Biotechnology | Il-4r antagonist for use in a method for treating or preventing asthma |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7608693B2 (en) * | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
| ES2332082B1 (en) * | 2008-07-24 | 2010-10-26 | Consejo Superior De Investigaciones Cientificas (Csic) 45% | PATTERN ALIGNMENT SYSTEM IN A SUBSTRATE BY LITOGRAPHY BY ESTENCIL. |
| WO2010029664A1 (en) * | 2008-09-10 | 2010-03-18 | 日本エクスラン工業株式会社 | Crosslinked acrylate-based fibers and the production thereof |
| BRPI1006519A2 (en) * | 2009-03-06 | 2016-08-09 | Genentech Inc | antibody formulation |
-
2011
- 2011-05-10 UA UAA201305598A patent/UA111731C2/en unknown
- 2011-10-03 AR ARP110103663 patent/AR083338A1/en not_active Application Discontinuation
- 2011-10-05 HU HUE18161288A patent/HUE052089T2/en unknown
- 2011-10-05 LT LTEP11770625.9T patent/LT2624865T/en unknown
- 2011-10-05 TW TW109107375A patent/TWI718890B/en active
- 2011-10-05 TW TW100135992A patent/TWI498121B/en active
- 2011-10-05 TW TW104123984A patent/TWI568445B/en active
- 2011-10-05 TW TW109131629A patent/TWI782325B/en active
- 2011-10-05 TW TW105134483A patent/TWI679988B/en active
- 2011-10-05 PT PT181612888T patent/PT3354280T/en unknown
- 2011-10-05 RS RS20181308A patent/RS57850B1/en unknown
- 2011-10-05 SI SI201131568T patent/SI2624865T1/en unknown
- 2011-10-05 TW TW108111631A patent/TWI690329B/en active
- 2011-10-05 ES ES18161288T patent/ES2820246T3/en active Active
- 2011-10-05 ES ES11770625.9T patent/ES2687813T3/en active Active
- 2011-10-05 DK DK11770625.9T patent/DK2624865T3/en active
- 2011-10-05 DK DK18161288.8T patent/DK3354280T3/en active
- 2011-10-06 UY UY33652A patent/UY33652A/en unknown
-
2018
- 2018-10-31 HR HRP20181822TT patent/HRP20181822T1/en unknown
-
2019
- 2019-01-15 HK HK19100671.5A patent/HK1258305A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW201716086A (en) | 2017-05-16 |
| TWI679988B (en) | 2019-12-21 |
| TWI782325B (en) | 2022-11-01 |
| TWI690329B (en) | 2020-04-11 |
| DK3354280T3 (en) | 2020-09-28 |
| DK2624865T3 (en) | 2018-10-22 |
| UY33652A (en) | 2012-04-30 |
| TW202320851A (en) | 2023-06-01 |
| ES2820246T3 (en) | 2021-04-20 |
| LT2624865T (en) | 2018-10-25 |
| SI2624865T1 (en) | 2018-10-30 |
| TW202026011A (en) | 2020-07-16 |
| PT3354280T (en) | 2020-09-01 |
| HRP20181822T1 (en) | 2018-12-28 |
| TW202102262A (en) | 2021-01-16 |
| RS57850B1 (en) | 2018-12-31 |
| ES2687813T3 (en) | 2018-10-29 |
| HK1258305A1 (en) | 2019-11-08 |
| TW201542229A (en) | 2015-11-16 |
| TW201924718A (en) | 2019-07-01 |
| AR083338A1 (en) | 2013-02-21 |
| TWI568445B (en) | 2017-02-01 |
| TWI498121B (en) | 2015-09-01 |
| TW201221141A (en) | 2012-06-01 |
| HUE052089T2 (en) | 2021-04-28 |
| TWI718890B (en) | 2021-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ609557A (en) | Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies | |
| UA107211C2 (en) | STABILIZED COMPOSITIONS CONTAINING ANTIBODIES TO THE INTERLACKINE 6 (IL-6R) RECEPTOR | |
| NZ627859A (en) | Stabilized formulations containing anti-ang2 antibodies | |
| NZ705178A (en) | Anti-prolactin receptor antibody formulations | |
| MX2009013558A (en) | Lyophilized immunoglobulin formulations and methods of preparation. | |
| UA111825C2 (en) | STABILIZED NGF ANTIBODY | |
| NZ602054A (en) | Anti-nerve growth factor (ngf) antibody compositions | |
| TR201909663T4 (en) | 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor-like-1 (fprl-1) receptor modulators. | |
| NZ629204A (en) | Anti-vla1 (cd49a) antibody pharmaceutical compositions | |
| UA116189C2 (en) | FORMULATION FOR ANTI-α4β7 ANTIBODY | |
| NZ601374A (en) | Stabilized antibody-containing liquid formulations | |
| FI3683235T3 (en) | Anti-il-33 antibodies and uses thereof | |
| PE20141028A1 (en) | NEW MODULATORS AND METHODS FOR THEIR USE | |
| EA201170396A1 (en) | 2-OXO-1,2-dihydroquinoline modulators of immune function | |
| UA113728C2 (en) | PHARMACEUTICAL COMPOSITION CONTAINING ANTIBODY TO AN PCSK9 HUMAN | |
| RU2014140137A (en) | ANTIBODY MEDICINE FOR BETA AMYLOID | |
| EA201290370A1 (en) | ANTIBODIES AGAINST FLT3 AND METHODS OF THEIR APPLICATION | |
| PE20141413A1 (en) | ANTIBODY FORMULATIONS AND METHODS | |
| EA201490420A1 (en) | TREATMENT OF DISEASES ASSOCIATED WITH α-SUBUNITS OF POTENTIAL-DEPENDENT SODIUM CHANNELS (SCNxA) WITH THE HELP OF SMALL MOLECULES | |
| UA111731C2 (en) | STABILIZED COMPOSITION CONTAINING ANTIBODY TO INTERLAYKIN-4 (IL-4R) RECEPTOR, OPTIONS | |
| IN2014DN03424A (en) | ||
| EA201490790A1 (en) | Peptide Conjugates of Gastrin and Glyukagon Receptor Agonists | |
| MX346500B (en) | Methods and compositions for neural disease immunotherapy. | |
| EA201291092A1 (en) | Heteroaryl cyclohexyl-tetraazabenzo [E] are altered as antagonists of vazopressin v1a | |
| EA201390467A1 (en) | ANTIBODY COMPOSITIONS AND METHODS OF APPLICATION |